According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

A simpler method of analyzing blood samples for Alzheimer's disease has been tested in a large multicenter study led by Lund ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. Researchers used ...

The woman’s brain was donated to research after her death, and it was analyzed by researchers for signs of Alzheimer’s ...

The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...

Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...

After adjusting for a slew of factors that can influence dementia risk, like age, sex, and education level, the researchers ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Protein clumps in the brain have long been associated with Alzheimer’s, but other potential causes of the condition are now ...

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now.

Alzheimer’s disease’s impact is growing as our population ages, but much of the disease’s pathophysiology remains unclear. A study published last year in the journal Nature revealed a ...